DRUG Earnings & Financial Statements
Bright Minds Biosciences Inc.
$23.00
+$2.30(+11.11%)
30
Overall
60
Value
9
Tech
23
Quality
Market Cap
$225.85M
Volume
197.38K
52W Range
$17.40 - $123.75
Target Price
$154.14
DRUG earnings and financial statements: Bright Minds Biosciences Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
DRUG Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating income | -$13.94M | -$2.82M | -$7.39M | -$14.98M |
| EBITDA | -$13.86M | -$2.71M | -$7.33M | -$14.96M |
| Net income | -$12.23M | -$2.78M | -$7.40M | -$14.96M |
| EPS (diluted) | $-1.78 | $-0.65 | $-1.98 | $-1.21 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $84.42M | $6.10M | $6.88M | $12.09M |
| Total liabilities | $2.38M | $568.3K | $280.9K | $1.54M |
| Shareholders’ equity | $82.04M | $5.54M | $6.60M | -$24.17M |
| Cash and equivalents | $82.91M | $5.72M | $6.75M | $11.63M |
| Long-term debt | $41.2K | $39.6K | - | $72.0K |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$8.69M | -$1.85M | -$7.02M | -$13.59M |
| Free cash flow | -$8.69M | -$1.85M | -$7.02M | -$13.59M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DRUG | $23.00 | +11.1% | 197.38K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bright Minds Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW